Submissions from 2024
Identifying and addressing a new barrier to community-based patients accessing cancer clinical trials, Melissa Fenech, Maegan Miklas, Abdulkadir Hussein, Youshaa El-Abed, Devinder Moudgil, Rhonda Abdel-Nabi, Kayla Touma, Mahmoud Hossami, Renee Nassar, Farwa Zaib, Sanghyuk Claire Rim, Roaa Hirmiz, Olla Hilal, Milica Paunic, Dora Cavallo-Medved, and Caroline Hamm
Submissions from 2022
Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells, Martin Crozier, Janice Tubman, Bre Anne Fifield, Rosa Maria Ferraiuolo, Jenna Ritchie, Katie Zuccato, Emily Mailloux, Indrajit Sinha, Caroline Hamm, and Lisa A. Porter
Fitted filtration efficiency and breathability of 2-ply cotton masks: Identification of cotton consumer categories acceptable for homemade cloth mask construction, Ken G. Drouillard, Amanda Tomkins, Sharon Lackie, Scott Laengert, Allison Baker, Catherine M. Clase, Charles F. De Lannoy, Dora Cavallo-Medved, Lisa A. Porter, and Rebecca S. Rudman
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis, Caroline Hamm, Dora Cavallo-Medved, Devinder Moudgil, Lee McGrath, John Huang, Yueyang Li, Tyler W. Stratton, Tyler Robinson, Krista Naccarato, Stephen Sundquist, and Janet Dancey
Submissions from 2019
Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate Cancer, Abedalrhman Alkhateeb, Iman Rezaeian, Siva Singireddy, Dora Cavallo-Medved, Lisa A. Porter, and Luis Rueda
A hierarchical machine learning model to discover gleason grade-specific biomarkers in prostate cancer, Osama Hamzeh, Abedalrhman Alkhateeb, Julia Zhuoran Zheng, Srinath Kandalam, Crystal Leung, Govindaraja Atikukke, Dora Cavallo-Medved, Nallasivam Palanisamy, and Luis Rueda